… monitoring tool, measurement of MRD is routinely performed using other methods as well—BM
morphology assessment, cytogenetics, fluorescence in situ hybridization … remission status …

… remission at 3 months after transplant with mild chronic graft-… , in the case of IFN, control
symptoms (as in our case 2). The … analysis, and fluorescence in situ hybridization (FISH) to …

… Karyotype and fluorescent in-situ hybridization are also … -negative complete remission”
into the European Leukemia Net’… Measurable residual disease monitoring by NGS before …

… Fluorescent in situ hybridization studies confirmed these … were in myeloid blast crisis of
chronic myeloid leukemia (CML). … of BCR-ABL1 fusion transcript surveillance can be used to …

… chromosome in chronic myelogenous leukemia followed by … ) of the control values are
used to evaluate a disomic pattern [Citation45]. … stage and during clinical remission [Citation95]. …

… with CML in chronic phase or in cytogenetic remission [18, 19]. … banding analysis and
fluorescence in situ hybridization (FISH… health donors were used as control. Informed consent was …

… Fluorescence in situ hybridization (FISH) analysis showed … and molecular remission, she
presented with severe headache, nausea, … irradiation can effectively control CNS disease and …

… 3 aberrations], thus complementary fluorescent in situ hybridisation (FISH) analysis is …
the same way as patients with complete molecular remission. In addition, CR with partial …

… can be detected by fluorescence in situ hybridization (FISH) or … Likewise, treatment free
remission was not assessed within … monitoring of BCR-ABL in chronic myelogenous leukemia …

… Patients require monitoring of complete blood count with … analysis or interphase fluorescence
in situ hybridization (FISH), … , cytogenetic, and molecular remissions, treatment failures as a …